Cargando…

Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with pol and LTR Targets in the Same Samples

For effective management of HIV-1 patients, accurate measurement of HIV-1-RNA viral load (VL) is fundamental. The latest generation molecular assays for monitoring VL perform simultaneous detection of two regions of the viral genome, but without specifying the target used for VL quantitation. By usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sberna, Giuseppe, Sarti, Silvia, Cicalini, Stefania, Antinori, Andrea, Garbuglia, Anna Rosa, Amendola, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603300/ https://www.ncbi.nlm.nih.gov/pubmed/36066258 http://dx.doi.org/10.1128/spectrum.01361-22

Ejemplares similares

Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference Assay
por: Wiesmann, Frank, et al.
Publicado: (2018)

Evaluation of the Aptima(®) HIV‐1 Quant Dx assay for HIV‐1 RNA viral load detection and quantitation in plasma of HIV‐1‐infected individuals: A comparison with Abbott RealTime HIV‐1 assay
por: Amendola, Alessandra, et al.
Publicado: (2016)

Analytical characteristics and comparative evaluation of Aptima HIV-1 Quant Dx assay with Ampliprep/COBAS TaqMan HIV-1 test v2.0
por: Hatzakis, Angelos., et al.
Publicado: (2016)

Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya
por: Mwau, Matilu, et al.
Publicado: (2022)

Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
por: Yan, Ying, et al.
Publicado: (2022)

Prospective evaluation of accuracy of HIV viral load monitoring using the Aptima HIV Quant Dx assay with fingerstick and venous dried blood spots prepared under field conditions in Kenya
por: Mwau, Matilu, et al.
Publicado: (2021)

Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0
por: Worlock, A., et al.
Publicado: (2017)

Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum
por: Schalasta, Gunnar, et al.
Publicado: (2016)

Evaluation of Aptima Zika Virus Assay
por: Ren, Ping, et al.
Publicado: (2017)

Comparison of the Aptima HIV‐1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV‐1 v2.0 Test for HIV‐1 viral load quantification in plasma samples from HIV‐1–infected patients
por: Longo, Serena, et al.
Publicado: (2018)

The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study
por: Schwebke, Jane R., et al.
Publicado: (2020)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
por: de Salazar, Adolfo, et al.
Publicado: (2019)

Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay
por: Manak, Mark M., et al.
Publicado: (2017)

Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples
por: Park, Younhee, et al.
Publicado: (2022)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol
por: Dhillon, Sharonjit K., et al.
Publicado: (2023)

Relationships of gag-pol diversity between Ty3/Gypsy and Retroviridae LTR retroelements and the three kings hypothesis
por: Llorens, Carlos, et al.
Publicado: (2008)

Synthetic Lethality Targeting Polθ
por: Drzewiecka, Małgorzata, et al.
Publicado: (2022)

The jmzQuantML programming interface and validator for the mzQuantML data standard
por: Qi, Da, et al.
Publicado: (2014)

QuantWorm: A Comprehensive Software Package for Caenorhabditis elegans Phenotypic Assays
por: Jung, Sang-Kyu, et al.
Publicado: (2014)

Changes in the Circulation of Common Respiratory Pathogens among Hospitalized Patients with Influenza-like Illnesses in the Lazio Region (Italy) during Fall Season of the Past Three Years
por: Sberna, Giuseppe, et al.
Publicado: (2022)

The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies
por: Guo, Yanli, et al.
Publicado: (2014)

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens
por: Trémeaux, Pauline, et al.
Publicado: (2020)

Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019
por: Weinbaum, Barbara, et al.
Publicado: (2020)

Assessment of the Performance of the Aptima Bacterial Vaginosis Assay Over a 3-Month Period in a French Hospital
por: Ruffier d’Epenoux, L., et al.
Publicado: (2022)

French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays
por: Le Roy, Chloé, et al.
Publicado: (2017)

MaxQuant.Live Enables Global Targeting of More Than 25,000 Peptides
por: Wichmann, Christoph, et al.
Publicado: (2019)

Triqler for MaxQuant: Enhancing Results from MaxQuant by Bayesian Error Propagation and Integration
por: The, Matthew, et al.
Publicado: (2021)

A yeast model for target-primed (non-LTR) retrotransposition
por: Goodwin, Timothy JD, et al.
Publicado: (2007)

BactQuant: An enhanced broad-coverage bacterial quantitative real-time PCR assay
por: Liu, Cindy M, et al.
Publicado: (2012)

FungiQuant: A broad-coverage fungal quantitative real-time PCR assay
por: Liu, Cindy M, et al.
Publicado: (2012)

SaQuant: a real-time PCR assay for quantitative assessment of Staphylococcus aureus
por: Wood, Colin, et al.
Publicado: (2021)

Prevalence of new variants of Chlamydia trachomatis escaping detection by the Aptima Combo 2 assay, England, June to August 2019
por: Roberts, David J, et al.
Publicado: (2019)

The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016)

Spotlight on the utility of the Oncotype DX(®) breast cancer assay
por: Siow, Zhen Rong, et al.
Publicado: (2018)

Nested plant LTR retrotransposons target specific regions of other elements, while all LTR retrotransposons often target palindromes and nucleosome-occupied regions: in silico study
por: Jedlicka, Pavel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7leovuqfsv1ch8qf796l3838k7